Linklaters advises Rhône on exclusive discussions to acquire majority share of Invacare Holdings and Direct Healthcare Group

Linklaters has advised investment vehicles affiliated with Rhône, the global private equity firm, on entering exclusive discussions to acquire a majority share of both Invacare Holdings and Direct Healthcare Group (DHG). This will bring together two companies with complementary capabilities and product lines in the design, manufacture, and distribution of medical devices that support an individual’s mobility, safety, and care.

Pending consultation processes with the relevant employee representative bodies and regulatory approvals, Rhône will hold a majority share in the combined business. DHG’s previous private equity backer, ARCHIMED, will retain a minority interest.

This investment and uniting of complementary portfolios will enable the combined business to address both major and nuanced mobility challenges, whether moving from A to B or making critical small adjustments to repositioning, delivering real impact for individuals, caregivers, and healthcare systems.

Together, Invacare and DHG will operate with an expanded global footprint and a broader product- and service-offering across mobility, pressure care, and rehabilitation, with the aim of becoming one of Europe’s leading providers in the post-acute mobility care sector.

The Linklaters team was led by Partners Ben Rodham, Peter McCabe and Managing Associates Tom Gavin and John Dai.